ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 40 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $52,147 | -98.3% | 48,000 | -98.4% | 0.00% | -100.0% |
Q3 2020 | $3,065,000 | -9.2% | 2,935,000 | -3.8% | 0.03% | -15.0% |
Q2 2020 | $3,377,000 | -14.3% | 3,051,000 | -20.9% | 0.04% | -9.1% |
Q1 2020 | $3,942,000 | +1278.3% | 3,859,000 | +1431.3% | 0.04% | +2100.0% |
Q4 2019 | $286,000 | -87.9% | 252,000 | -87.8% | 0.00% | -88.9% |
Q3 2019 | $2,361,000 | -55.1% | 2,069,000 | -53.3% | 0.02% | -52.6% |
Q2 2019 | $5,264,000 | +79.9% | 4,427,000 | +104.7% | 0.04% | +58.3% |
Q1 2019 | $2,926,000 | +85.9% | 2,163,000 | +45.7% | 0.02% | +140.0% |
Q3 2018 | $1,574,000 | -46.5% | 1,485,000 | -50.5% | 0.01% | -37.5% |
Q2 2018 | $2,943,000 | +506.8% | 3,003,000 | +512.9% | 0.02% | +433.3% |
Q1 2018 | $485,000 | -76.4% | 490,000 | -75.6% | 0.00% | -72.7% |
Q4 2016 | $2,051,000 | +196.4% | 2,012,000 | +106.4% | 0.01% | +266.7% |
Q2 2016 | $692,000 | -25.1% | 975,000 | +18.8% | 0.00% | -40.0% |
Q4 2015 | $924,000 | – | 821,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TENOR CAPITAL MANAGEMENT Co., L.P. | 74,881,000 | $76,559,000 | 1.97% |
III Capital Management | 15,000,000 | $15,227,000 | 1.82% |
TFG Asset Management GP Ltd | 14,055,000 | $14,321,000 | 1.02% |
MACKAY SHIELDS LLC | 28,304,000 | $28,739,000 | 0.21% |
RWC Asset Management LLP | 6,500,000 | $6,604,000 | 0.20% |
PALISADE CAPITAL MANAGEMENT, LP | 7,187,000 | $7,281,000 | 0.17% |
CQS (US), LLC | 4,000,000 | $4,092,000 | 0.13% |
FARALLON CAPITAL MANAGEMENT LLC | 24,435,000 | $24,797,000 | 0.12% |
D. E. Shaw & Co., Inc. | 59,728,000 | $60,845,000 | 0.06% |
BNP Paribas Asset Management Holding S.A. | 7,000,000 | $7,133,000 | 0.03% |